Devonian Health Group
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
360 Des Entrepreneurs Rue, Montmagny, Qu...Phone Number
(514) 248-7509Website
www.groupedevonian.comRevenue
<$5 MillionStock Symbol
GSDIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Devonian Health Group
Devonian Health Group Inc. is a botanical drug company specializing in treatments for inflammatory-autoimmune diseases, with a focus on gastrointestinal, dermatological, and hepatologic conditions. Their flagship product, Thykamine, is under development for conditions such as ulcerative colitis, atopic dermatitis, and psoriasis, showcasing its anti-inflammatory and antioxidant properties. Additionally, the company offers a range of cosmeceutical products, including anti-aging and sun care items for both men and women. Devonian is committed to developing novel therapeutics and generating shareholder value through its advanced product pipeline.Explore more
Devonian Health Group Org Chart
DT
Chief Financial Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Devonian Health Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Devonian Health Group, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Devonian Health Group has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Devonian Health Group has new funding data
Click to see if Devonian Health Group had a recent Job posting/layoffs
Check out if Devonian Health Group is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Devonian Health Group
Product Launch: Get notified when Devonian Health Group launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Devonian Health Group recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Devonian Health Group is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Devonian Health Group is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Devonian Health Group.
Devonian Health Group financials insights
Gather financial insights about Devonian Health Group, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$1.8M
Devonian Health Group Tech Stack
A closer look at the technologies used by Devonian Health Group
See more technologies
Most Recent Scoops
Project
Product Development, Product Management, Governmental Affairs & Regulation, Pharmaceuticals, Clinical Operations, Regulations
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Person-Based
Devonian Health Group News & Media
Devonian Health Group Receives Health Canada Authorization to Initiate Phase II/III Pediatric Clinical Trial of Thykamine™ for Mild-to-Moderate Atopic Dermatitis in Patients Aged 3 Months to 17 Years
The primary objective of the study is to evaluate the efficacy of Thykamine™ compared with placebo in the treatment of mild-to-moderate pediatric atopic dermatitis after 12 weeks of twice-daily treatment. Secondary objectives include assessment of the overall safety and tolerability. The...Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30, 2026
(all amounts are in Canadian dollars) Quarter ended April 30, 2026, net loss of $1.9 million dollars, ($0.70) per share Nine months ended April 30, 2026, net loss of $5.7 million dollars, ($2.07) per share Cash as of April 30, 2026, $0.7 million Company remains debt-free QUÉBEC, June 29,...Devonian Reports Results of its Annual General and Special Meeting of Shareholders
QUÉBEC, March 30, 2026 /PRNewswire/ - Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today highlights the results of its...Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January 31, 2026
(all amounts are in Canadian dollars) Quarter ended January 31, 2026, net loss of $2.2 million dollars, ($0.81) per share Six months ended January 31, 2026, net loss of $3.8 million dollars, ($1.37) per share Cash as of January 31, 2026, $1.3 million; Company remains debt-free Reverse...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Devonian Health Group
Sign Up For FreeTo access detailed company insights
Devonian Health Group Inc. is a botanical drug company specializing in treatments for inflammatory-autoimmune diseases, with a focus on gastrointestinal, dermatological, and hepatologic conditions. Their flagship product, Thykamine, is under development for conditions such as ulcerative colitis, atopic dermatitis, and psoriasis, showcasing its anti... Read More
